## Abstract This trial evaluated the reactogenicity, kinetics of antibody induction, and longโterm immunogenicity of a 720 enzymeโlinked immunosorbent assay units (EL. U.) antigen dose of an inactivated hepatitis A vaccine (Havrix(tm), SmithKline Beecham Biologicals, Rixensart, Belgium). One hundre
Inactivated hepatitis A vaccine: long-term antibody persistence
โ Scribed by G. Wiedermann; M. Kundi; F. Ambrosch; A. Safary; E. D'Hondt; A. Delem
- Book ID
- 117432413
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 534 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
To estimate the long-term persistence of anti-HAV antibodies, 120 (schedule 0-6) and 194 (schedule 0-12) adults were vaccinated and followed-up annually for 6 years. Shortly after the last dose, anti-HAV levels fell sharply (annual decline rate delta > 65%). Thereafter, delta diminished to 10-15%. G
Very few studies with inactivated hepatitis A vaccines were designed for long-term follow-up of antibody persistence. Based on the serological data from these vaccine trials, mathematical models were developed to predict the decrease of anti-hepatitis A virus (anti-HAV) antibodies after vaccination.
## Abstract Longโterm persistence of vaccineโinduced immune response in adults was assessed annually for 15 years following primary immunization with a twoโdose inactivated hepatitis A vaccine. In 1992, 119 and 194 subjects aged 17โ40 years and naรฏve for hepatitis A virus (HAV) were enrolled in two
Antibody response to hepatitis B vaccination was measured in 97 institutionalized, mentally handicapped patients after a 0-, 1-, 6-month vaccination schedule. Two groups were formed at month 7 according to the antibody response, which determined whether they needed an additional vaccine dose at mont
## Abstract The aim of this study was to predict the longโterm protection induced after immunisation with inactivated, aluminiumโfree virosome hepatitis A vaccine. The study population consisted of adult volunteers enrolled in four different clinical trials. Lower 95% confidence interval limits and